Anzeige
Mehr »
Login
Mittwoch, 25.09.2024 Börsentäglich über 12.000 News von 690 internationalen Medien
BREAKING NEWS: Nachbörsliche Hammermeldung - explodiert die Aktie morgen weiter?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
220 Leser
Artikel bewerten:
(1)

TravelPerk partners with Divvy to bring best in class travel and expense experience to U.S. business travelers

CHICAGO, June 29, 2021 /PRNewswire/ -- TravelPerk, the largest global business travel management platform, announced today a new partnership with Divvy, the leading spend and expense management platform to bring the best business travel and expense management experience on the planet. Through the collaboration, TravelPerk becomes Divvy's primary travel partner, providing employees of small and midsize businesses (SMBs) with a simpler way to book, manage, and pay for what they need when travelling for work, while also giving finance teams a central place to control, manage, and track spend.

As their teams begin traveling again, SMBs cannot afford to lose time and money due to employees booking out-of-policy work trips, exceeding spending limits, or incorrectly filing expenses. Additionally, utilizing leisure travel sites for business purposes results in poor visibility for finance teams monitoring travel spend and expenses.

Divvy Travel, powered by TravelPerk, addresses this problem and solves many challenges SMBs face in the current travel experience, including significant amounts of lost time and money, and lack of transparency into business expenditures.

Divvy Travel benefits include:

  • A simplified, central portal for employees to easily book and manage travel - from booking to expensing
  • Exceptional visibility and control for finance teams across all business spending
  • Saved time and money for all employees - from travelers to managers to finance teams

The partnership comes at a time when businesses are opening back up and need to be positioned to grow, while staying on budget. Divvy and TravelPerk have both navigated the COVID-19 landscape in innovative ways, doubling down on their commitment to small- and medium-sized businesses. Both Divvy and TravelPerk are confident that SMBs will be an engine of economic recovery because of their size and agility.

Starting today, Divvy's U.S. business clients can enjoy full access to the TravelPerk platform, which offers the world's largest flight, hotel, and ground transportation inventory, 24/7 customer support, and a fast and reliable reporting system. They will also gain access to TravelPerk's innovative range of products and services, including TravelCare and FlexiPerk, to help their employees navigate travelling post-Covid-19. TravelPerk Premium and Pro customers will also have access to Divvy's free spend management solution, simplifying the process of business travel expense reports.

"We are excited to be launching this partnership and combining the expertise of both TravelPerk and Divvy to deliver the best capabilities and experience for our customers," said Ross McNairn, Chief Product and Technology Officer at TravelPerk. "By recognising each other's strengths and expertise, we are able to set new standards for employees and businesses that we think our customers will love."

"We're thrilled to partner with TravelPerk to empower business owners with easy-to-use software that controls spend," said Sterling Snow, Chief Revenue Officer at Divvy. "With a comprehensive expense and travel process, Divvy and TravelPerk can save finance teams precious time and money."

About TravelPerk

TravelPerk is the next-generation business travel platform pioneering the future of business travel. TravelPerk's all-in-one platform gives travelers the freedom they want whilst providing companies with the control they need. The result is saved time, money, and hassle for everyone.

TravelPerk has the world's largest travel inventory alongside powerful management features, 24/7 customer support, state-of-the-art technology and consumer-grade design, all of which are enabling companies worldwide to get the most out of their travel.

Backed by world-class investors like DST, Kinnevik, Target Global, Felix Capital, Greyhound Capital, Spark Capital, Heartcore, LocalGlobe, Amplo, 14W-investors in some of the most disruptive companies in tech including Zalando, Slack, Trello, Twitter, Farfetch and Delivery Hero - TravelPerk is reinventing business travel with an end-to-end solution that works. Visit www.travelperk.com or https://www.travelperk.com/divvy/ for more information.

© 2021 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.